Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.86 USD | -2.02% | -3.19% | +12.24% |
05-02 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Puma Biotechnology, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024 | CI |
Business Summary
Number of employees: 185
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cancer Care Products
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 228 | 100.0 % | 236 | 100.0 % | +3.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Investor Relations Contact | - | - | |
Jeffrey Ludwig
PRN | Corporate Officer/Principal | 58 | 20-02-29 |
Douglas Hunt
LAW | General Counsel | 59 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Director/Board Member | 63 | 22-07-28 | |
Director/Board Member | 60 | 15-08-10 | |
Troy Wilson
BRD | Director/Board Member | 55 | 13-10-17 |
Allison Dorval
BRD | Director/Board Member | 48 | 21-07-14 |
Brian Stuglik
BRD | Director/Board Member | 64 | 20-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 48,238,850 | 40,808,140 ( 84.60 %) | 0 | 84.60 % |
Company contact information
Puma Biotechnology, Inc.
10880 Wilshire Boulevard Suite 2150
90024-4101, Los Angeles
+
http://www.pumabiotechnology.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.24% | 234M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- PBYI Stock
- Company Puma Biotechnology, Inc.